This webinar will discuss treatment considerations for transitional-age youth with intellectual/developmental disabilities and co-morbid SMI. It will review the common co-morbid medical conditions in this population that can influence the choice in therapeutic agent, as well as the current evidence and guidelines available to help support clinical decision-making..

Presenter: Rebecca McCloskey, PMHNP-BC, Boston Psychiatric Care